Goat IgG anti-Human IgG (Fc)-Biotin, MinX none

Catalog Number: DNA-SEC-183041
Article Name: Goat IgG anti-Human IgG (Fc)-Biotin, MinX none
Biozol Catalog Number: DNA-SEC-183041
Supplier Catalog Number: SEC-183041
Alternative Catalog Number: DNA-SEC-183041
Manufacturer: dianova
Host: Goat
Category: Antikörper
Application: ELISA,IHC,WB
Species Reactivity: Human
Immunogen: Human IgG F(c) fragment
Conjugation: Biotin
Alternative Names: Goat Anti Human IgG Fc Biotin Conjugated Antibody, Goat Anti-Human IgG F(c) Antibody Biotin conjugated, Goat Anti Human IgG Fc Fragment Antibody Biotin conjugation
Format: IgG
Target Specificity: IgG (Fc)
Cross-Adsorption (MinX): no cross-adsorbtion
Anti-Human IgG F(c) Biotin Conjugated generated in goat detects Human F(c). A proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme papain under controlled conditions of temperature, time and pH. Receptors bind the
Clonality: Polyclonal
Concentration: 2.0 mg/mL
Isotype: Ig
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Purity: This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.   Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-biotin, anti-Goat Serum, Human IgG, Human IgG F(c) and Human Serum.  No reaction was observed against Human IgG F(ab).
Form: Lyophilized
Formula: 20 mM K3PO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% NaN3
Target: Human
Antibody Type: Secondary Antibody
Application Dilute: ELISA Dilution: 1:20,000 - 1:100,000, Immunohistochemistry Dilution: 1:1,000 - 1:5,000, Western Blot Dilution: 1:2,000 - 1:10,000
Application Notes: Anti-Human IgG F(c) Biotin Conjugated is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.